Activation of <scp>CD</scp>4<sup>+</sup><scp>F</scp>oxp3<sup>+</sup> regulatory <scp>T</scp> cells proceeds normally in the absence of <scp>B</scp> cells during <scp>EAE</scp>
Kai Hoehlig(Charité - Universitätsmedizin Berlin), Simon Fillatreau(Hôpital Necker-Enfants Malades), Richard A. O’Connor(Queen's Medical Centre), Ping Shen(Humboldt-Universität zu Berlin), Stefanie Ries(Charité - Universitätsmedizin Berlin), Ellen Hilgenberg, Stephen M. Anderton(Centre for Inflammation Research), Vicky Lampropoulou(National and Kapodistrian University of Athens), Bernard MALISSEN(Centre National de la Recherche Scientifique), Toralf Roch(Charité - Universitätsmedizin Berlin)
Cited by 37
Related Papers
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
|Nucleic Acids Research|2017|1.7k
B cells regulate autoimmunity by provision of IL-10
|Nature Immunology|2002|1.6k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
|Nature|2014|1k
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
|The Journal of Experimental Medicine|2012|651